DÄ internationalArchiveReferences
References

Editorial

Blessèd Pain Relief

Dtsch Arztebl Int 2013; 110(4): 43-4. DOI: 10.3238/arztebl.2013.0043

Koppert, W

1.Schubert I, Ihle P, Sabatowski R: Increase in opiate prescription in Germany between 2000 and 2010—a study based on insurance data. Dtsch Arztebl Int 2013; 110(4): 45–51 VOLLTEXT
2.Portenoy RK, Hagen NA: Breakthrough pain: definition, prevalence and characteristics. Pain 1990; 41: 273–81. CrossRef MEDLINE
3.Mercadante S: What is the definition of breakthrough pain? Pain 1991; 45: 107–8. CrossRef MEDLINE
4.U.S. Food and Drug Administration: Safety alert for fentanyl buccal tablets. J Pain Palliat Care Pharmacother 2008; 22: 47. CrossRef MEDLINE
5.Passik SD, Messina J, Golsorkhi A, Xie F: Aberrant drug-related behavior observed during clinical studies involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet for breakthrough pain. J Pain Symptom Manage 2011; 41: 116–25. CrossRef MEDLINE
6.Scascighini L, Toma V, Dober-Spielman S, Sprott H: Multidisciplinary treatment for chronic pain: a systematic review of interventions and outcomes. Rheumatology 2008; 47: 670–8. CrossRef MEDLINE
7.Arnold B, Brinkschmidt T, Casser HR: Multimodale Schmerztherapie – Konzepte und Indikation. Schmerz 2009; 23: 112–20. CrossRef MEDLINE
8.Nagel B, Pfingsten M, Brinkschmidt T, et al.: Struktur- und Prozessqualität multimodaler Schmerztherapie. Schmerz 2012; 26: 661–6. CrossRef MEDLINE
9.Meissner W, Mescha S, Rothaug J, Zwacka S, Goettermann A, Ulrich K, Schleppers A: Quality improvement in postoperative pain management: results from the QUIPS project. Dtsch Arztebl Int 2008; 105: 865–70. VOLLTEXT
10.Casser HR, Hüppe M, Kohlmann T, Korb J, Lindena G, Maier C, Nagel B, Pfingsten M, Thoma R: Deutscher Schmerzfragebogen (DSF) und standardisierte Dokumentation mit KEDOQ-Schmerz. Schmerz 2012; 26: 168–75. CrossRef MEDLINE

Info

Figures and tables

Authors

Authors

Specialities